GTN Sorbitrate -CR 6.4 Tablet

generic_icon
Rs.392for 1 bottle(s) (30 tablet cr each)
1
दुर्दैवाने आमच्याकडे संग्रहात घटक शिल्लक नाहीत.
दुस-या प्रकारात उपलब्ध
एररची सूचना द्या

GTN Sorbitrate 6.4mg Tablet CR साठी संमिश्रण

Nitroglycerin(6.4mg)

GTN Sorbitrate Tablet CR साठी कृती अन्न

GTN Sorbitrate Tablet CR साठी कृती दारू

GTN Sorbitrate Tablet CR साठी कृती गर्भधारणा

GTN Sorbitrate Tablet CR साठी कृती स्तनपान

अन्न
दारू
गर्भधारणा
स्तनपान
GTN Sorbitrate -CR 6.4 Tablet ला अन्नासोबत किंवा शिवाय घेतले जाऊ शकते परंतु ते एका विशिष्ठ वेळी घ्यावे.
GTN Sorbitrate -CR 6.4 Tablet मुळे अल्कोहोलसोबत कदाचित फ्लशिंग, हृदयाचे वाढलेले ठोके, मळमळ, तहान, छातीत वेदना आणि कमी रक्तदाबात (डिसुल्फिरम अभिक्रिया) परिणाम होऊ शकतो. काही नाही
UNSAFE
GTN Sorbitrate -CR 6.4 Tablet गर्भारपणात सुरक्षित असू शकते.
भरपूर आणि नियंत्रीत प्राण्यांवरील अभ्यास भ्रूणावर कमी किंवा शून्य जोखीम दर्शवतात, परंतू मानवी अभ्यास मर्यादित आहेत. कृपया तुमच्या डॉक्टरांचा सल्ला घ्या.
SAFE IF PRESCRIBED
GTN Sorbitrate -CR 6.4 Tablet बहुधा स्तनपान करवण्याच्या दरम्यान वापरण्यास सुरक्षित आहे. मर्यादित मानवीय आकडेवारीवरुन दिसते की या औषधामुळे बाळाला लक्षणीय जोखीम होणार नाही.
SAFE IF PRESCRIBED

GTN Sorbitrate 6.4mg Tablet CR साठी क्षार माहिती

Nitroglycerin(6.4mg)

Gtn sorbitrate tablet cr वापरते

GTN Sorbitrate -CR 6.4 Tablet/Glyceryl Trinitrate ला हृदयविकाराचा (चेस्ट वेदना)च्या उपचारात वापरले जाते.

Gtn sorbitrate tablet crकसे कार्य करतो

GTN Sorbitrate -CR 6.4 Tablet हृदयावरील बोजा कमी करते. ज्यामुळे हृदयाच्या स्नायुंना जास्त रक्त आणि ऑक्सीजनची आवश्यकता लागत नाही.

Gtn sorbitrate tablet cr चे सामान्य दुष्प्रभाव

डोकेदुखी, डोके हलके होणे

GTN Sorbitrate Tablet CR साठी विकल्प

56 विकल्प
56 विकल्प
Sorted By
RelevancePrice

GTN Sorbitrate 6.4mg Tablet CRसाठी नेहमी विचारले जाणारे प्रश्न

Nitroglycerin

Q. Can I take sildenafil if I am taking GTN Sorbitrate -CR 6.4 Tablet?
No, you should not take sildenafil if you are taking GTN Sorbitrate -CR 6.4 Tablet. Taking these two medicines together can cause an excessive fall in blood pressure, which may even be life-threatening.
Q. What effect does GTN Sorbitrate -CR 6.4 Tablet have on blood pressure?
GTN Sorbitrate -CR 6.4 Tablet decreases the blood pressure by relaxing the blood vessels, but is not recommended for the treatment of high blood pressure. The drop in blood pressure may cause lightheadedness, especially when changing your position suddenly.
Q. Does the effect of GTN Sorbitrate -CR 6.4 Tablet wear off after some time?
Yes, excessive use of GTN Sorbitrate -CR 6.4 Tablet may cause tolerance which means that GTN Sorbitrate -CR 6.4 Tablet may lose its effectiveness on you. Therefore, usually the doctors prescribe the smallest dose required for effective relief of acute angina attack. This helps maintain the effectiveness of GTN Sorbitrate -CR 6.4 Tablet.
Show More
Q. What does too much GTN Sorbitrate -CR 6.4 Tablet do?
Excess GTN Sorbitrate -CR 6.4 Tablet may result in low blood pressure, sweating, nausea, vomiting, headache, weak and fast pulse. It may also cause weakness, lightheadedness on standing and the patient might even faint. The patient will require emergency medical treatment in such a case.
Q. Can I stop using GTN Sorbitrate -CR 6.4 Tablet as I feel better now?
Stopping GTN Sorbitrate -CR 6.4 Tablet suddenly may bring on attacks of angina, especially if you have been using it for several weeks or more. Talk to your doctor who will advise you to reduce the dose gradually over 4 to 6 weeks before you stop using it completely.
Q. Does GTN Sorbitrate -CR 6.4 Tablet stop heart attacks?
GTN Sorbitrate -CR 6.4 Tablet is prescribed to prevent attacks of heart-related chest pain (angina) in patients with coronary artery disease. In this disease the blood vessels (coronary arteries) which supply blood to the heart become narrowed because of which the heart has to work harder to get enough oxygen. GTN Sorbitrate -CR 6.4 Tablet prevents angina by relaxing the blood vessels so that the heart does not have to work very hard. Also, relaxation of coronary arteries increases the oxygen supply to the heart.

Content on this page was last updated on 04 November, 2024, by Dr. Varun Gupta (MD Pharmacology)